None listed
Conditions
Brief summary
Multi-centre study investigating whether specific nutritional interventions improve pressure injury healing compared to standard care. Consenting eligible patients with pressure injuries stage 2 or greater at 5 south East Queensland hospitals will be randomized to receive standard ward based nutrition, intensive dietetic nutrition intervention or prescription of a wound healing formula. Data will be collected at baseline and weekly including a range of relevant demographic, nutritional and pressure ulcer measurements.
Interventions
Patients will be randomized to one of the following groups: a. Standard nutritional care by clinical team that may or may not include dietetic intervention, high protein/energy diet and/or nutritional supplement. b. intensive individualised nutritional intervention provided by an associate investigator site dietitian aimed to meet estimated nutritional requirements of patients on a daily basis, which will likely include a high protein/energy diet and supplements (but not including wound healing supplements). Estimated nutritional requirements will be determined at 1.2g protein/kg and 30 KCal/kg per day. Patient will be reviewed by a dietitian for appox 20-30 minutes 3-4 times per week to assess intake and modify nutritional care plan if required. c. standard care as described above, plus the provision of a nutritional supplements developed specifically to enhance wound healing ie complete oral liquid nutritional formulas enriched with Arginine, Vitamin C and Zinc. Supplements will be prescribed based on manufacturers recommendations ie 2 or 3 200-250ml tetrapaks daily. Patients will be given a choice of two different brands of supplements based on their preferences. Supplement A contains per 200ml bottle: 20g protein (of which arginine is 3.0g), 250 KCal, 9 mg Zinc, 250 mg Vitamin C Recommended dose is 3 200ml bottles per day. Supplement B contains per 250ml tetrapak: 21 g protein (of which arginine is 4.5g), 250 KCal, 15 mg Zinc, 250 mg Vitamin C. Recommended dose is 2 250 ml tetrapaks per day. Duration of interventions will be for the duration of patient hospital stay. Compliance with interventions will be monitored through data collection of food and fluid (including supplement) intake.
Sponsors
Study design
Eligibility
Inclusion criteria
Inpatients (adults) of 5 acute hospitals with pressure ulcer/injury stage 2 or greater.
Exclusion criteria
Stage 1 of deep tissue pressure injury Patients unable to receive nutrition via enteral route Patients inappropriate for intensive nutrition support ie palliative care Patients unable to follow nutrition support advise ie cognitively impaired Pregnancy Previously recruited to study